Fundz

Who to call at BioNTech, and when

Fundz watches for the moments BioNTech starts buying, and tells you who to reach.

  • An alert the day BioNTech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioNTech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioNTech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

BioNTech Acquires Biotheus, Gains Control of Investigational Bispecific Antibody

Nov 13, 2024

Contract Type

partnership

MainzBiotechnologyHealth CareTherapeuticsBiopharma

Description

BioNTech has announced the acquisition of development partner Biotheus, which includes gaining full control of an investigational bispecific antibody aimed at dethroning checkpoint inhibitors as the standard treatment for solid tumors. The agreement involves an $800 million upfront payment, along with the promise of up to $150 million in certain milestones.

Company Information

Company

BioNTech

Location

Mainz, Rhineland Palatinate, Germany

About

BioNTech is a biopharmaceutical company dedicated to harnessing the power of the immune system to develop innovative cancer therapies and treatments for other serious diseases.

Related People

Luca
Senior decision-maker at this company
••••••••@••••••••

See Luca's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for BioNTech's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

BioNTech signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.